This issue of InforMS describes the serious efforts of expert physicians to identify the best strategies to treat people with multiple sclerosis. Unfortunately, however, there is another critical decision maker…
Read More
The Medicaid Buy-In Program: An Overlooked Option for Social Security Recipients and Others Incapable of Work for Medical Reasons
By Thomas Stewart, MS, JD, PA-CInforMS: Spring 2018The critical safety net for most disabled Americans is Social Security Disability Insurance (SSDI). By providing an income to some people with disabilities, SSDI has prevented many from experiencing the…
March 30, 2018
You're Reading:
About the Author

Tom Stewart is both an Attorney and Physician Assistant, and has been involved in the medical and legal care of MS patients for more than two decades.
More From This Issue:
InforMS: Winter 2025
MS Research Today: Expanding Horizons
From new treatment targets and trial designs to broader inclusion and predictive biomarkers, MS research is entering a new era focused on progression, precision, and quality of life. For...
InforMS: Winter 2025
Remembering Patricia Daily
We are deeply saddened to share the news of the passing of our colleague and friend, Patricia Daily. Many in our community knew Pat, worked alongside her, or benefited from...
InforMS: Winter 2025
BTK Inhibitors: A New Class Focused on Progression
A research emphasis on measuring relapses and tracking MRIs naturally leads to a treatment emphasis on preventing relapses and reducing MRI activity. And of course, both are still important. But...
InforMS: Winter 2025
Lifestyle and Brain Health: What You Can Influence
One encouraging thread across recent studies is how daily habits can build cognitive reserve — the brain’s ability to work around damage — while also improving mood, sleep, and physical...
InforMS: Winter 2025
The Evolving Research of Discontinuing DMTs
One of the most common topics that comes up in RMMSC education programs and Q&A sessions is the question of discontinuing disease-modifying therapies (DMTs). Patients want to know when they...
InforMS: Winter 2025
Moving the Needle: One Participant’s Journey Through MS Research
For this issue of InforMS, we sat down with David Dombeck, a research participant at the Rocky Mountain MS Center at the University of Colorado. David was diagnosed later in...
InforMS: Winter 2025


